One of the key pieces of advice for MedTech start-ups is to start developing a reimbursement strategy from day one, because even the best idea without a reimbursement strategy would be worthless. The ‘problem to solution’ approach is crucial when it comes to attracting VC attention but is nothing without a solid revenue model and pricing strategy. Navigating European funding systems can be a challenge for start-ups, as each national healthcare system has its own characteristics: different levels of reimbursement decisions, fees paid per service, etc. This session therefore aims to map current payment systems for innovative medical technologies and procedures, including concrete initiatives to transform reimbursement and funding systems. Speakers will provide a practical overview of reimbursement pathways in the EU and share case studies and success stories.
Where can MedTech innovators go for reimbursement support in the EU? How can companies familiarise themselves with the decision-making process and engage with key stakeholders? What are the most important reimbursement considerations when targeting France, Germany, Belgium or the UK? What about new pathways emerging for digital health solutions such as DiGA or PECAN?
Moderator: Carole Absil, HealthTech Strategist 
